141 related articles for article (PubMed ID: 10428308)
1. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.
Steins MB; Padró T; Li CX; Mesters RM; Ostermann H; Hammel D; Scheld HH; Berdel WE; Kienast J
Atherosclerosis; 1999 Jul; 145(1):173-80. PubMed ID: 10428308
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Padró T; Steins M; Li CX; Mesters RM; Hammel D; Scheld HH; Kienast J
Cardiovasc Res; 1997 Oct; 36(1):28-36. PubMed ID: 9415269
[TBL] [Abstract][Full Text] [Related]
3. Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries.
Kienast J; Padró T; Steins M; Li CX; Schmid KW; Hammel D; Scheld HH; van de Loo JC
Thromb Haemost; 1998 Mar; 79(3):579-86. PubMed ID: 9531045
[TBL] [Abstract][Full Text] [Related]
4. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator system in human coronary atherosclerosis.
Raghunath PN; Tomaszewski JE; Brady ST; Caron RJ; Okada SS; Barnathan ES
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1432-43. PubMed ID: 7670959
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator expression in human atherosclerotic lesions.
Lupu F; Heim DA; Bachmann F; Hurni M; Kakkar VV; Kruithof EK
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1444-55. PubMed ID: 7670960
[TBL] [Abstract][Full Text] [Related]
7. Expression of the plasminogen activator system in the human vascular wall.
Salame MY; Samani NJ; Masood I; deBono DP
Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide system gene expression in human coronary arteries.
Casco VH; Veinot JP; Kuroski de Bold ML; Masters RG; Stevenson MM; de Bold AJ
J Histochem Cytochem; 2002 Jun; 50(6):799-809. PubMed ID: 12019296
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.
Chen F; Eriksson P; Hansson GK; Herzfeld I; Klein M; Hansson LO; Valen G
Int J Mol Med; 2005 Jan; 15(1):57-65. PubMed ID: 15583828
[TBL] [Abstract][Full Text] [Related]
10. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
11. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis.
Nakata A; Miyagawa J; Yamashita S; Nishida M; Tamura R; Yamamori K; Nakamura T; Nozaki S; Kameda-Takemura K; Kawata S; Taniguchi N; Higashiyama S; Matsuzawa Y
Circulation; 1996 Dec; 94(11):2778-86. PubMed ID: 8941102
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries.
Chen YX; Nakashima Y; Tanaka K; Shiraishi S; Nakagawa K; Sueishi K
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):131-9. PubMed ID: 9888875
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen and plasmin activity in patients with coronary artery disease.
Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
[TBL] [Abstract][Full Text] [Related]
14. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.
Newby DE; McLeod AL; Uren NG; Flint L; Ludlam CA; Webb DJ; Fox KA; Boon NA
Circulation; 2001 Apr; 103(15):1936-41. PubMed ID: 11306520
[TBL] [Abstract][Full Text] [Related]
15. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery.
Hoshiga M; Alpers CE; Smith LL; Giachelli CM; Schwartz SM
Circ Res; 1995 Dec; 77(6):1129-35. PubMed ID: 7586225
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase.
O'Brien KD; Deeb SS; Ferguson M; McDonald TO; Allen MD; Alpers CE; Chait A
Am J Pathol; 1994 Mar; 144(3):538-48. PubMed ID: 8129039
[TBL] [Abstract][Full Text] [Related]
18. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
Lupu F; Bergonzelli GE; Heim DA; Cousin E; Genton CY; Bachmann F; Kruithof EK
Arterioscler Thromb; 1993 Jul; 13(7):1090-100. PubMed ID: 7686395
[TBL] [Abstract][Full Text] [Related]
19. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone.
Tyagi SC; Smiley LM; Mujumdar VS; Clonts B; Parker JL
Mol Cell Biochem; 1998 Apr; 181(1-2):107-16. PubMed ID: 9562247
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery.
Clowes AW; Clowes MM; Au YP; Reidy MA; Belin D
Circ Res; 1990 Jul; 67(1):61-7. PubMed ID: 2114227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
